BSCG IS A PROUD PARTNER IN THE BOARD OF MEDICINE CLINICAL CANNABIS INITIATIVE

Banned Substances Control Group (BSCG) is proud to announce a partnership with the Board of Medicine. The Board of Medicine is a 501(c)(3) nonprofit Medical Board establishing the first peer-reviewed evidence-based clinical guidelines for the production, sale, and use of currently unregulated medicines like CBD. The partnership is born out of the Board of Medicine’s vision to improve the safety and effectiveness of alternative medical treatments for both patients and health care providers alike and BSCG’s role as a third-party certification and testing provider to help ensure the safety and integrity of consumer products like dietary supplements or CBD products. This exciting partnership helps elevate the Certified CBD program within the medical community and offers discounts on the Certified CBD program to brands that work with the Board of Medicine.

CLINICAL CANNABIS INITIATIVE ENSURES HIGH QUALITY CBD PRODUCTS

The Board of Medicine is a consortium of physicians, scientists, and subject matter experts working together to provide access to evidence-based, peer-reviewed, and data-driven knowledge through their Clinical Cannabis Initiative. This is to ensure the safety of unregulated medicine like CBD for caregivers, patients, and industry partners. The Board of Medicine and BSCG have aligned goals and values making for a natural partnership. The Board of Medicine recognizes BSCG and the Certified CBD program as an international leader in third-party certification and testing built on a foundation of more than 25 years at the forefront of sport drug testing and anti-doping science.

This partnership with an esteemed group of doctors establishes BSCG as a premiere CBD testing provider working to ensure the best possible CBD products are available to medical providers interested in alternative medicine but wary about quality concerns in the CBD industry. It also provides Board of Medicine brand partners with access to the BSCG Certified CBD program, the most robust banned substance and quality control certification available in the CBD realm and the first of its kind in the industry.

At BSCG, we specialize in banned substance testing, label claim verification, environmental contaminant testing, and Good Manufacturing Practices (GMP) compliance for dietary supplements, CBD products, cosmetics and more. It’s thanks to our commitment to excellence that the Board of Medicine has approved BSCG as a qualified partner and testing provider in their Clinical Cannabis Initiative.

CLINICAL CANNABIS INITIATIVE ENSURES HIGH QUALITY CBD PRODUCTS

The Board of Medicine is a consortium of physicians, scientists, and subject matter experts working together to provide access to evidence-based, peer-reviewed, and data-driven knowledge through their Clinical Cannabis Initiative. This is to ensure the safety of unregulated medicine like CBD for caregivers, patients, and industry partners. The Board of Medicine and BSCG have aligned goals and values making for a natural partnership. The Board of Medicine recognizes BSCG and the Certified CBD program as an international leader in third-party certification and testing built on a foundation of more than 25 years at the forefront of sport drug testing and anti-doping science.

This partnership with an esteemed group of doctors establishes BSCG as a premiere CBD testing provider working to ensure the best possible CBD products are available to medical providers interested in alternative medicine but wary about quality concerns in the CBD industry. It also provides Board of Medicine brand partners with access to the BSCG Certified CBD program, the most robust banned substance and quality control certification available in the CBD realm and the first of its kind in the industry.

At BSCG, we specialize in banned substance testing, label claim verification, environmental contaminant testing, and Good Manufacturing Practices (GMP) compliance for dietary supplements, CBD products, cosmetics and more. It’s thanks to our commitment to excellence that the Board of Medicine has approved BSCG as a qualified partner and testing provider in their Clinical Cannabis Initiative.

The rigorous certification approach for CBD products achieves the following:

Verification of CBD quality specifications
Ensures the integrity of ingredients and finished products
Increased consumer confidence and awareness
Hemp supplier verification and licensing
Screening Phytocannabinoids and environmental contaminant testing
Standard turnaround time is usually 20 business days after sample receipt.
Drug testing protection from THC and drugs banned in sport
A compliance review that considers claims and the quality control process

WHY THIRD-PARTY TESTING IS VITAL FOR CBD

As the CBD industry is unregulated currently there have been a number of quality concerns surrounding the expanding realm of CBD products. These challenges have resulted in some in the medical community being resistant to considering CBD and has also impacted consumer confidence in the category. The BSCG Certified CBD program is a complete quality control solution for hemp and CBD product brands. Certification includes: a daily limit on ingestion of tetrahydrocannabinol (THC) to protect against positive drug tests and psychoactive effects; verification of the amount of CBD and other cannabinoids on the label; screening for 507+ pharmaceutical contaminants including 298 on the World Anti-Doping Agency Prohibited List and 209 prescription, OTC and illicit drugs; comprehensive testing for environmental contaminants including heavy metals, pesticides, and microbiological agents; and an extensive initial quality control and compliance review.